Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Rein Therapeutics Inc. (RNTX) had Non-Operating Income/Expense of $-0.09M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.58M |
|
-- |
|
-- |
|
$5.49M |
|
$-5.49M |
|
|
Non-Operating Income/Expense |
$-0.09M |
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.49M |
|
$-5.49M |
|
26.36M |
|
26.36M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$5.17M |
|
-- |
|
$48.53M |
|
$53.71M |
|
$5.74M |
|
-- |
|
$46.78M |
|
$52.52M |
|
$1.19M |
|
$-47.34M |
|
$1.19M |
|
25.14M |
|
| Cash Flow Statement Financials | |
$-16.14M |
|
-- |
|
$7.35M |
|
$12.87M |
|
$4.05M |
|
$-8.82M |
|
$1.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-470.97% |
|
11.79% |
|
-10.39% |
|
-470.97% |
|
$0.05 |
|
$-0.61 |
|
$-0.61 |
|